By The Associated Press
THE DEAL: Pfizer Inc., the world's largest drug company, on Monday agreed to buy NextWave Pharmaceuticals Inc. in a deal worth as much as $700 million.
THE TERMS: Earlier this year Pfizer paid $20 million for an option to buy NextWave. It is exercising that option and will pay $255 million when the deal closes. Pfizer also agreed to make up to $425 million in sales milestone payments.
THE PRODUCT: NextWave recently received marketing approval for Quillivant XR, a once-per-day liquid intended to treat attention deficit hyperactivity disorder. It plans to launch the drug in January.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.